Total Visits

Views
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice112

Select a period of time:

Views

Views
November 20257
December 20254
January 20261
February 20260
March 202614
April 20268
May 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
United Kingdom4
Morocco3
Brazil3
Ecuador2
Finland2
Mexico2
Argentina2
Austria1
Australia1
 

Top cities views

Views
Helsinki2
Mexico City2
San Jose2
Guayaquil2
Addis Ababa1
Agadir1
Bel Alton1
Botucatu1
Brooklyn1
Buenos Aires1